Home › Kleincellige longkanker › Massachusetts › Boston
Kleincellige longkanker klinische studies in Boston, MA
21 studies voor Kleincellige longkanker zoeken deelnemers op locaties in en rond Boston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
RekruterenFase 2
- Dana-Farber Cancer Institute /ID# 277732, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- Dana Farber Cancer Institute, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruterenFase 1/2
- Tufts Medical Center, Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruterenFase 3
- Dana-Farber Cancer Institute /ID# 279690, Boston
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RekruterenFase 1
- Massachusetts General Hospital, Boston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
RekruterenFase 1/2
- Dana Farber Cancer Institute ( Site 1105), Boston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Boston
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
RekruterenFase 1/2
- Dana Farber Cancer Institute, Boston
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RekruterenFase 2
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Massachusetts General Hospital Cancer Center, Boston
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RekruterenFase 3
- Dana-Farber Cancer Institute, Boston
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
RekruterenFase 1
- Massachusetts General Hospital, Boston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruterenFase 1
- Beth Israel Deaconess Medical Center, Boston
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
RekruterenFase 2
- Dana Farber Cancer Institute, Boston
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- Massachusetts General Hospital, Boston
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
RekruterenFase 2
- Tufts Medical Center, Boston
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
RekruterenObservatieonderzoek
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- en nog 1
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Massachusetts General Hospital, Boston
- Harvard School of Public Health, Boston
Kleincellige longkanker studies in andere steden
- Houston, TX26 studies
- Arlington, VA23 studies
- New York City, NY22 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- Cleveland, OH13 studies
- Chicago, IL13 studies
- St. Louis, MO13 studies
- Detroit, MI12 studies
- Washington, DC12 studies
Andere studies in Boston
- Borstkanker112 studies
- Niet-kleincellige longkanker90 studies
- Kanker (alle vormen)85 studies
- Metastatische kanker63 studies
- Colorectale kanker63 studies
- Longkanker62 studies
- Eierstokkanker61 studies
- Prostaatkanker59 studies
- Depressie52 studies
- Endometriumkanker50 studies
- Hartfalen44 studies
- Acute myeloïde leukemie44 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.